Lung cancer is the most common cancer in the western world. Only 10 to 15 % of patients
diagnosed with lung cancer are suitable for potentially curative surgical treatment. Despite
surgery, recurrence of lung cancer still occurs. Aspirin potentially may help increase
survival by altering the biochemistry of any potential remaining lung cancer cells. Most lung
cancer occurs in smokers. Smokers are at increased risk of heart attacks and strokes. Aspirin
has beneficial effects on the heart and brain, potentially reducing the incidence of heart
attacks and strokes.
Phase:
Phase 3
Details
Lead Sponsor:
Liverpool Heart and Chest Hospital NHS Foundation Trust